Beyer is an M.D./Ph.D. candidate at Harvard Medical School and the Harvard T. H. Chan School of Public Health. As a pediatrician and a scientist-in-training, I conduct research on a critical question ...
Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Imugene Ltd. (ASX: IMU) resuming coverage. The research summary ...
When major stock market indices, such as the S&P 500 (SPX), trend down, investors applying a broad market approach to investing may want to shift to tailoring more selective portfolios. The goal would ...
Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. Equity markets are shaped by shifting macro conditions, evolving business models, and ...
In 2022, equity analysts spent more time back on the road than ever — and institutional investors were waiting for them. “The relaxation of travel and meeting restrictions globally has resulted in a ...
NEW YORK--(BUSINESS WIRE)--Clear Street, (“Clear Street”, “the Company”) a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, today announced the expansion of ...
It was another rollercoaster year in the equity markets. Investors wanted just one thing from sell-side research in 2021: more. “There was a lot going on in the world, and the buy side continues to ...
Historically, the ability to conduct research has been limited to those with power, privilege, and resources. While grantmaking provides significant resources to fund research, those resources have ...
Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Michael Ciarmoli will join the firm’s equity research department as a Managing ...
Learn everything you need to know about T. Rowe Price US Equity Research ETF (TSPA) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it ...
Business Insider is seeking nominations for the top equity research analysts who are 35 and under. We want to hear from you about people who have stood out in the world of sell-side equity research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results